Skip to main content
Premium Trial:

Request an Annual Quote

Craig Venter, Steven Block, Jeffrey Dangl, Kevin Krenitsky, G. Mason Morfit, Jonathan Roy

Premium
Arizona State University will grant Craig Venter an honorary doctorate at its commencement ceremony on May 10. Venter is chairman and CEO of the J. Craig Venter Institute.
 

 
Steven Block and Jeffrey Dangl are among 72 new members elected to the National Academy of Sciences. Block is a professor of applied physical and biological sciences at Stanford University, and published a paper on single-molecule sequencing last year (see GenomeWeb News 08/14/2006)
 
Dangl is John N. Couch distinguished professor at the University of North Carolina, Chapel Hill, and associate director of the Carolina Center for Genome Sciences.
 

 
Kevin Krenitsky has become CEO of genomics services firm BioServe. Prior to joining BioServe, Krenitsky was CEO of Parkway Clinical Laboratories, a clinical diagnostic testing lab. Prior to that, he was senior vice president and division head at SeraCare Life Sciences’ Genomics Collaborative biobanking division. Krenitsky was medical director at Genomics Collaborative before it was acquired by SeraCare in 2004. Last week, BioServe acquired the Genomics Collaborative business from SeraCare for an undisclosed sum.
 
Krenitsky replaces Ramakrishna Modali. Modali, who founded BioServe, is now listed on the company’s website as president.
 

 
Valeant Pharmaceuticals has elected former Solexa director G. Mason Morfit to its board of directors. Morfit is a partner with ValueAct Capital, Valeant's largest stockholder. Prior to joining ValueAct, Morfit worked in equity research for Credit Suisse First Boston.
 

 
NanoString Technologies has appointed Jonathan Roy as vice president of sales.
 
Roy comes to NanoString from Alfa Wassermann Proteomic Technologies, where he was vice president of commercial operations. Previously, he was regional business manager for the Southeastern US for Roche Applied Science, North American sales manager for Dynal Biotech’s molecular division, and held a variety of sales management positions at Applied Biosystems.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.